Epigral
BSE 543332
3 stories, newest first.
- Epigral schedules Elara Securities investor/analyst plant visit at Dahej on 22 October 2026
- Epigral to hold one-on-one video meeting with Elara Securities (India) Pvt Ltd on 14 October 2026
- Analyst recommended staying invested in Epigral with a target of 1050-1080, citing strong revenue growth plans
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.